ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 9,700.00
-340.00 (-3.39%)
At close: Feb 6, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 719.4 billion as of February 6, 2026.
Market Cap
719.40B
Enterprise Value
687.82B
Revenue
715.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
9,700.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has increased from 547.53B to 719.40B, an increase of 31.39%. That is a compound annual growth rate of 46.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 719.40B | -25.50% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HK inno.N | 1.50T |
| G2GBIO | 1.31T |
| Myung In Pharmaceutical LTD. | 903.74B |
| Samyang Biopharm | 696.00B |
| HEM Pharma | 633.63B |
| CellBion | 324.00B |
| DAE HWA Pharmaceutical | 264.85B |
| NOVAREX | 253.85B |